Recall: D-0166-2027

Class II - Potentially Harmful

Class IIClassification
2026-10-20Initiated
OngoingStatus
Hikma Pharmaceuticals USA INC.Firm

Product

Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9929-50

Reason

CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.

Distribution

US Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.